Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07810322 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pilot Testing of the emPath Platform to Improve Medication for Opioid Use Disorder (MOUD) Linkage and Retention Among Adults With Opioid Use Disorder in Durham, North Carolina

Name: Pilot Testing of the emPath Platform to Improve Medication for Opioid Use Disorder (MOUD) Linkage and Retention Among Adults With Opioid Use Disorder in Durham, North Carolina — clinical trial record (NCT07810322)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot applicable

SponsorDuke University

Started2026-07-29

View on ClinicalTrials.gov ↗

Duke University

455 trials monitored

See 53 trials at risk

This pilot study will evaluate the emPath digital platform, a platform designed to improve access to and retention in low-barrier telemedicine for delivery of medication for opioid use disorder (MOUD) among adults with opioid use disorder who engage with community outreach programs in Durham, North Carolina.

Trial Details

NCT Number	NCT07810322
Lead Sponsor	Duke University
Conditions	Opioid Use Disorder, Digital Health Intervention, Telemedicine, Outreach Intervention
Enrollment	80 participants
Start Date	2026-07-29
Primary Completion	2027-03-31 (estimated)
Study Completion	2027-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-09-09